Table 4:
Variable | Total | Non-frail | Pre-frail | Frail | P a |
---|---|---|---|---|---|
MIS | −0.39 ± 4.01 (N = 130) | −1.24 ± 2.48 (N = 42) | −0.11 ± 4.04 (N = 55) | 0.21 ± 5.30 (N = 33) | .238 |
Albumin | 0.05 ± 0.39 (N = 130) | 0.15 ± 0.25 (N = 42) | 0.00 ± 0.31 (N = 55) | −0.02 ± 0.59 (N = 33) | .101 |
Cholesterol | −3.79 ± 28.20 (N = 129) | 0.90 ± 24.00 (N = 41) | −2.16 ± 28.42 (N = 55) | −12.33 ± 31.46 (N = 33) | .113 |
Transferrin | −1.54 ± 30.00 (N = 130) | 1.19 ± 25.39 (N = 42) | −1.09 ± 29.54 (N = 55) | −5.76 ± 36.06 (N = 33) | .606 |
SPPB | −0.33 (1.76) | −0.08 (1.19) | −0.80 (2.02) | 0.39 (1.79) | .025 |
ANOVA test. The P-value shows whether there is a difference in the evolution in each of the three groups between basal and final visits.